Formulation Development For Scalability: Manufacturing Strategies For Bioavailability-Enhancing Technologies

An early-phase formulation strategy for poorly soluble molecules is essential for overcoming potential challenges in manufacturing, bioavailability, and stability. It can include the selection of excipients that enhance bioavailability and manufacturing technologies that are amenable to scale up and the production of a dosage form that meets the USP dose uniformity requirements. Download the article to learn how up-front planning and suitable formulations and manufacturing development strategies can potentially reduce project timelines and costs and result in scalable, bioavailable, and stable formulations.

Click here to view the Article